Chirality 1999-01-01

Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum.

J Szymura-Oleksiak, M Walczak, J Bojarski, H Y Aboul-Enein

Index: Chirality 11(4) , 267-71, (1999)

Full Text: HTML

Abstract

A stereoselective direct liquid chromatographic method for assay of the enantiomers of the beta-adrenergic blocker acebutolol (AC) and its active metabolite, diacetolol (DC), in human serum was developed. The assay is based on extraction with ethyl acetate and separation of enantiomers on an amylose tris-(3,5-dimethylphenylcarbamate) chiral stationary phase (Chiralpak AD) column. The method was validated and proved useful for the determination of the enantiomers in serum samples of patients suffering from hypertension and chronically treated with racemic AC. The results were compared and found similar with an indirect assay based on derivatization of the enantiomers with (+)-(S)-1-(1-naphthyl)ethyl isocyanate (NEIC).

Related Compounds

  • Diacetolol

Related Articles:

Using supported liquid extraction together with cellobiohydrolase chiral stationary phases-based liquid chromatography with tandem mass spectrometry for enantioselective determination of acebutolol and its active metabolite diacetolol in spiked human plasma.

2009-01-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 877(3) , 173-80, (2009)]

Acebutolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.

1986-01-01

[Pharmacotherapy 6(2) , 45-63, (1986)]

Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.

1984-04-01

[J. Pharm. Pharmacol. 36(4) , 276-7, (1984)]

Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.

1985-01-01

[Biopharm. Drug Dispos. 6(2) , 131-7, (1985)]

Displacement of [3H]dihydroalprenolol binding from rat heart and lung by acebutolol, diacetolol and D-diacetolol.

1983-03-01

[J. Pharm. Pharmacol. 35(3) , 198-9, (1983)]

More Articles...